Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects-Reference-Cited by-同舟云学术

Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects

Published:2020-10 Issue: Volume:64 Page:101976
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Huang Ying,Assam Pryseley Nkouibert,Feng Cong,Su Rong,Dorinsky Paul,Gillen Michael^ORCID

Funder

AstraZeneca

AstraZeneca, Gaithersburg, USA

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference31 articles.

1. Is exposure to biomass smoke the biggest risk factor for COPD globally?;Salvi;Chest,2010

2. Global and regional estimates of COPD prevalence: systematic review and meta-analysis;Adeloye;J Glob Health,2015

3. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethnic Sensitivity Study of the Extrafine, Single-Inhaler, Triple Therapy Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide Pressurized Metered Dose Inhaler in Japanese and Caucasian Healthy Individuals: A Randomized, Double-Blind, Single-Dose Crossover Study;Clinical Therapeutics;2021-11

2. Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease;Annals of Pharmacotherapy;2021-08-12

3. Budesonide/Glycopyrronium/Formoterol: A Review in COPD;Drugs;2021-08